Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women’s and general health, eye health, gastrointestinal diseases, and toxicology worldwide. More Details
Flawless balance sheet with outstanding track record.
Share Price & News
How has Quidel's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: QDEL is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: QDEL's weekly volatility (8%) has been stable over the past year.
7 Day Return
US Medical Equipment
1 Year Return
US Medical Equipment
Return vs Industry: QDEL underperformed the US Medical Equipment industry which returned 30.4% over the past year.
Return vs Market: QDEL underperformed the US Market which returned 34.7% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Quidel's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 weeks ago | Simply Wall StQuidel Corporation (NASDAQ:QDEL) Analysts Are Reducing Their Forecasts For This Year
2 months ago | Simply Wall StQuidel Corporation's (NASDAQ:QDEL) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
2 months ago | Simply Wall StWe Take A Look At Why Quidel Corporation's (NASDAQ:QDEL) CEO Compensation Is Well Earned
Is Quidel undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: QDEL ($145.87) is trading above our estimate of fair value ($33.73)
Significantly Below Fair Value: QDEL is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: QDEL is good value based on its PE Ratio (6.5x) compared to the US Medical Equipment industry average (49x).
PE vs Market: QDEL is good value based on its PE Ratio (6.5x) compared to the US market (18x).
Price to Earnings Growth Ratio
PEG Ratio: QDEL's earnings are forecast to decline next year, so we can't calculate its PEG ratio.
Price to Book Ratio
PB vs Industry: QDEL is good value based on its PB Ratio (4.2x) compared to the US Medical Equipment industry average (4.4x).
How is Quidel forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: QDEL's earnings are forecast to decline over the next 3 years (-47.6% per year).
Earnings vs Market: QDEL's earnings are forecast to decline over the next 3 years (-47.6% per year).
High Growth Earnings: QDEL's earnings are forecast to decline over the next 3 years.
Revenue vs Market: QDEL's revenue is expected to decline over the next 3 years (-21.8% per year).
High Growth Revenue: QDEL's revenue is forecast to decline over the next 3 years (-21.8% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: QDEL's Return on Equity is forecast to be low in 3 years time (10.5%).
How has Quidel performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: QDEL has high quality earnings.
Growing Profit Margin: QDEL's current net profit margins (50.9%) are higher than last year (15.7%).
Past Earnings Growth Analysis
Earnings Trend: QDEL has become profitable over the past 5 years, growing earnings by 87% per year.
Accelerating Growth: QDEL's earnings growth over the past year (973.6%) exceeds its 5-year average (87% per year).
Earnings vs Industry: QDEL earnings growth over the past year (973.6%) exceeded the Medical Equipment industry 34.8%.
Return on Equity
High ROE: QDEL's Return on Equity (63.6%) is considered outstanding.
How is Quidel's financial position?
Financial Position Analysis
Short Term Liabilities: QDEL's short term assets ($1.3B) exceed its short term liabilities ($366.9M).
Long Term Liabilities: QDEL's short term assets ($1.3B) exceed its long term liabilities ($240.7M).
Debt to Equity History and Analysis
Debt Level: QDEL is debt free.
Reducing Debt: QDEL has no debt compared to 5 years ago when its debt to equity ratio was 70.7%.
Debt Coverage: QDEL has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: QDEL has no debt, therefore coverage of interest payments is not a concern.
What is Quidel current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate QDEL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate QDEL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if QDEL's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if QDEL's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of QDEL's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Doug Bryant (63 yo)
Mr. Douglas C. Bryant, also known as Doug, has been the Chief Executive Officer and President of Quidel Corporation since March 1, 2009. Mr. Bryant served as the Chief Operating Officer and Executive Vice ...
CEO Compensation Analysis
Compensation vs Market: Doug's total compensation ($USD7.18M) is about average for companies of similar size in the US market ($USD6.50M).
Compensation vs Earnings: Doug's compensation has increased by more than 20% in the past year.
Experienced Management: QDEL's management team is considered experienced (3.8 years average tenure).
Experienced Board: QDEL's board of directors are considered experienced (4.5 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Quidel Corporation's company bio, employee growth, exchange listings and data sources
- Name: Quidel Corporation
- Ticker: QDEL
- Exchange: NasdaqGS
- Founded: 1979
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: US$6.207b
- Shares outstanding: 42.55m
- Website: https://www.quidel.com
Number of Employees
- Quidel Corporation
- 9975 Summers Ridge Road
- San Diego
- United States
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women’s and general health, eye health, gastrointestinal di...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/08/04 23:02|
|End of Day Share Price||2021/08/04 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.